Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

The effect of two dose levels of eicosapentaenoic acid (EPA) on apoptosis and cell proliferation in the colonic mucosa of patients with a history of colonic polyps.

Trial Profile

The effect of two dose levels of eicosapentaenoic acid (EPA) on apoptosis and cell proliferation in the colonic mucosa of patients with a history of colonic polyps.

Completed
Phase of Trial: Phase II/III

Latest Information Update: 15 Nov 2008

At a glance

  • Drugs Eicosapentaenoic acid (Primary)
  • Indications Colonic polyps; Colorectal cancer
  • Focus Therapeutic Use
  • Sponsors SLA Pharma
  • Most Recent Events

    • 15 Nov 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 16 Oct 2008 Actual end date (Jun 2008) added as reported by ClinicalTrials.gov.
    • 16 Mar 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top